CoChat
Sign Up
Cited by 170Nutritional Studies and DietDementia and Cognitive Impairment ResearchFatty Acid Research and Health

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK Biobank prospective cohort study

Open access
Shannon, Oliver M., Ranson, Janice M., Gregory, Sarah, Macpherson, Helen, Milte, Catherine, Lentjes, Marleen, Mulligan, Angela, McEvoy, Claire, Griffiths, Alex, Matu, Jamie, Hill, Tom R., Adamson, Ashley, Siervo, Mario, Minihane, Anne Marie, Muniz-Tererra, Graciela, Ritchie, Craig, Mathers, John C., Llewellyn, David J., Stevenson, Emma·2023·BMC Medicine
DOI 10.1186/s12916-023-02772-3PMC PMC10012551
Open this paper in CoChat — free accountOpen PDF

Abstract

Background: The identification of effective dementia prevention strategies is a major public health priority, due to the enormous and growing societal cost of this condition. Consumption of a Mediterranean diet (MedDiet) has been proposed to reduce dementia risk. However, current evidence is inconclusive and is typically derived from small cohorts with limited dementia cases. Additionally, few studies have explored the interaction between diet and genetic risk of dementia. Methods: We used Cox proportional hazard regression models to explore the associations between MedDiet adherence, defined using two different scores (Mediterranean Diet Adherence Screener [MEDAS] continuous and Mediterranean diet Pyramid [PYRAMID] scores), and incident all-cause dementia risk in 60,298 participants from UK Biobank, followed for an average 9.1 years. The interaction between diet and polygenic risk for dementia was also tested. Results: Higher MedDiet adherence was associated with lower dementia risk (MEDAS continuous: HR = 0.77, 95% CI = 0.65–0.91; PYRAMID: HR = 0.86, 95% CI = 0.73–1.02 for highest versus lowest tertiles). There was no significant interaction between MedDiet adherence defined by the MEDAS continuous and PYRAMID scores and polygenic risk for dementia. Conclusions: Higher adherence to a MedDiet was associated with lower dementia risk, independent of genetic risk, underlining the importance of diet in dementia prevention interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-023-02772-3

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Association between MedDiet adherence and risk of dementia (n = 60,298, including 882 dementia cases). MedDiet adherence level was split into tertiles, with the dashed line reflecting the low MedDiet adherence reference group for each MedDiet score
Fig. 1 Association between MedDiet adherence and risk of dementia (n = 60,298, including 882 dementia cases). MedDiet adherence level was split into tertiles, with the dashed line reflecting the low MedDiet adherence reference group for each MedDiet scoreCC BY · PubMed Central
Fig. 2 Association between MedDiet adherence and risk of dementia in sub-group and sensitivity analyses. MedDiet adherence level was split into tertiles, with the dashed line reflecting the low MedDiet adherence reference group for each MedDiet score. Analyses include: A) Primary analyses for the MEDAS, MEDAS continuous and PYRAMID scores (n = 60,298, including 882 dementia cases); B) Including participants with a minimum of 2 dietary reports (n = 38,794, including 479 dementia cases); C) After excluding participants with extreme energy intakes (n = 59,627, including 867 dementia cases); D) Excluding participants with less than 2 years (n = 59,594, including 843 dementia cases) and 5 years (n = 58,196, including 698 dementia cases) follow up; E) Adjusting for potential mediators, including BMI (n = 60,163, including 876 dementia cases), history of depression (n = 58,837, including 851 dementia cases), or stroke (n = 60,298, including 882 dementia cases); F) Stratified into low (n = 21,009, including 261 dementia cases), medium (n = 20,000, including 313 dementia cases) and high (n = 19,273, including 308 dementia cases) genetic risk categories; G) Stratified into APOE4 carriers (n = 16,644, including 467 dementia cases) and non-carriers (n = 43,651, including 415 dementia cases); H) With imputed missing data (n = 196,335, including 5001 dementia cases); I) Restricted to fatal (n = 59,627, including 260 dementia cases) and non-fatal (n = 60,038, including 622 dementia cases) dementia cases; and J) Stratified into higher (n = 33,281, including 430 dementia cases) and lower (n = 27,007, including 452 dementia cases) education status groups
Fig. 2 Association between MedDiet adherence and risk of dementia in sub-group and sensitivity analyses. MedDiet adherence level was split into tertiles, with the dashed line reflecting the low MedDiet adherence reference group for each MedDiet score. Analyses include: A) Primary analyses for the MEDAS, MEDAS continuous and PYRAMID scores (n = 60,298, including 882 dementia cases); B) Including participants with a minimum of 2 dietary reports (n = 38,794, including 479 dementia cases); C) After excluding participants with extreme energy intakes (n = 59,627, including 867 dementia cases); D) Excluding participants with less than 2 years (n = 59,594, including 843 dementia cases) and 5 years (n = 58,196, including 698 dementia cases) follow up; E) Adjusting for potential mediators, including BMI (n = 60,163, including 876 dementia cases), history of depression (n = 58,837, including 851 dementia cases), or stroke (n = 60,298, including 882 dementia cases); F) Stratified into low (n = 21,009, including 261 dementia cases), medium (n = 20,000, including 313 dementia cases) and high (n = 19,273, including 308 dementia cases) genetic risk categories; G) Stratified into APOE4 carriers (n = 16,644, including 467 dementia cases) and non-carriers (n = 43,651, including 415 dementia cases); H) With imputed missing data (n = 196,335, including 5001 dementia cases); I) Restricted to fatal (n = 59,627, including 260 dementia cases) and non-fatal (n = 60,038, including 622 dementia cases) dementia cases; and J) Stratified into higher (n = 33,281, including 430 dementia cases) and lower (n = 27,007, including 452 dementia cases) education status groupsCC BY · PubMed Central
Fig. 3 Association between MedDiet adherence defined by the MEDAS (A), MEDAS continuous (B) and PYRAMID (C) scores and risk of dementia (n = 60,298, including 882 dementia cases) after sequentially removing each MedDiet component from the total score. Hazard ratios and 95% CIs were estimated per point increased in MedDiet score
Fig. 3 Association between MedDiet adherence defined by the MEDAS (A), MEDAS continuous (B) and PYRAMID (C) scores and risk of dementia (n = 60,298, including 882 dementia cases) after sequentially removing each MedDiet component from the total score. Hazard ratios and 95% CIs were estimated per point increased in MedDiet scoreCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. World Health Organization. Risk Reduction of Cognitive Decline and Dementia. Geneva: World Health Organization; 2019.

Cited by

Sorted by citations

See all 170

Related

Metadata

Authors
Shannon, O. M., Ranson, J. M., Gregory, S., Macpherson, H., Milte, C., Lentjes, M., Mulligan, A., McEvoy, C., Griffiths, A., Matu, J., Hill, T. R., Adamson, A., Siervo, M., Minihane, A. M., Muniz-Tererra, G., Ritchie, C., Mathers, J. C., Llewellyn, D. J., & Stevenson, E.
Affiliations
  • Newcastle University (GB)
  • University of Exeter (GB)
  • University of Edinburgh (GB)
  • Deakin University (AU)
  • Örebro University (SE)
  • University of Cambridge (GB)
  • Queen's University Belfast (GB)
  • Leeds Beckett University (GB)
  • University of Nottingham (GB)
  • University of East Anglia (GB)
Corresponding author
Mathers, John C.
ORCID
Venue
BMC Medicine
Publisher
Springer Science and Business Media LLC
Published
2023-03-14
Volume
21
Issue
1
Pages
81-81
ISSN
1741-7015 (ISSN-L)
DOI
10.1186/s12916-023-02772-3
PMC
PMC10012551
OpenAlex
W4324029343
Cited by
167
References
44
Citations by year
2026: 43 · 2025: 49 · 2024: 62 · 2023: 13
FWCI
42.75
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
  • Leeds Beckett Repository (Leeds Beckett University) (acceptedVersion, other-oa)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Open Research Exeter (University of Exeter) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
Funders
Medical Research Council (MR/T001852/1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Keywords
Mediterranean diet, dietary adherence, dementia risk, dementia prevention, polygenic risk, genetic susceptibility, Mediterranean Diet Adherence Screener, Mediterranean diet pyramid, UK Biobank
MeSH terms
Dementia, United Kingdom, Humans, Prospective Studies, Biological Specimen Banks, Genetic Predisposition to Disease, Diet, Mediterranean

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review